FDG PET: advantages for staging the mediastinum?

被引：10

作者：

Franzius, C ^{[1
]}

机构：

[1] Univ Hosp Munster, Dept Nucl Med, D-48149 Munster, Germany

来源：

LUNG CANCER | 2004年 / 45卷

关键词：

FDG; PET; imaging; staging; mediastinum; lung cancer;

D O I：

10.1016/j.lungcan.2004.07.990

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Correctly staging lung cancer is extremely important because treatment options and prognosis differ significantly by stage. In this review, the performance characteristics of positron emission tomography using F-18-fluoro-deoxyglucose (FDG PET) for staging the mediastinum are given in comparison with other non-invasive imaging modalities on the basis of current literature data. There are three meta-anatyses demonstrating that FDG PET is more accurate than CT for detecting mediastinal metastases. First publications suggest that dual-modality PET-CT may provide a further gain in accuracy. Additionally, whole-body FDG PET provides information on M-staging and prognosis. Data comparing FDG PET with other functional imaging modalities or endoscopic ultrasound are limited. The necessity of a histological confirmation of PET results is still under discussion. (C) 2004 Elsevier Science Ltd.

引用

页码：S69 / S74

页数：6

共 29 条

[1]

Ahuja V, 1998, CANCER, V83, P918, DOI 10.1002/(SICI)1097-0142(19980901)83:5<918::AID-CNCR17>3.3.CO

[2]

2-#

[3] Non-small cell lung cancer: Dual-modality PET/CT in preoperative staging [J].

Antoch, G ;

Stattaus, J ;

Nemat, AT ;

Marnitz, S ;

Beyer, T ;

Kuehl, H ;

Bockisch, A ;

Debatin, JF ;

Freudenberg, LS .

RADIOLOGY, 2003, 229 (02) :526-533

[4] A multicenter trial with a somatostatin analog 99mTc depreotide in the evaluation of solitary pulmonary nodules [J].

Blum, J ;

Handmaker, H ;

Lister-James, J ;

Rinne, N .

CHEST, 2000, 117 (05) :1232-1238

[5]

Coleman RE, 2002, LANCET, V359, P1361

[6] Comparative impact of standard approach, FDG PET and FDG dual-head coincidence gamma camera imaging in preoperative staging of patients with non-small-cell lung cancer [J].

Delahaye, N ;

Crestani, B ;

Rakotonirina, H ;

Lebtahi, R ;

Sarda, L ;

Girard, P ;

Charpentier, E ;

Fery-Lemonnier, E ;

Syrota, A ;

Aubier, M ;

LE Guludec, D ;

Fdg, FP .

NUCLEAR MEDICINE COMMUNICATIONS, 2003, 24 (12) :1215-1224

[7] Invasive staging - The guidelines [J].

Detterbeck, FC ;

DeCamp, MM ;

Kohman, LJ ;

Silvestri, GA .

CHEST, 2003, 123 (01) :167S-175S

[8] Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results [J].

Dietlein, M ;

Weber, K ;

Gandjour, A ;

Moka, D ;

Theissen, P ;

Lauterbach, KW ;

Schicha, H .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (11) :1598-1609

[9] Metastases from non-small cell lung cancer: Mediastinal staging in the 1990s - Meta-analytic comparison of PET and CT [J].

Dwamena, BA ;

Sonnad, SS ;

Angobaldo, JO ;

Wahl, RL .

RADIOLOGY, 1999, 213 (02) :530-536

[10] FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy [J].

Eschmann, SM ;

Friedel, G ;

Paulsen, F ;

Budach, W ;

Harer-Mouline, C ;

Dohmen, BM ;

Bares, R .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (06) :804-808

← 1 2 3 →